Biotech News
Related news
XGNExagen2026-10-27 13:00 EST
Exagen to Announce Third Quarter Financial Results on November 10, 2026
HCWBHCW Biologics2026-11-16 13:15 EST
HCW Biologics Reports Third Quarter 2026 Business and Clinical Development Highlights and Financial Results
OSUROraSure Technologies, Inc.2026-11-09 21:05 EST
OraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin Expansion
SNGXSOLIGENIX2026-11-06 12:30 EST
Soligenix Announces Recent Updates and Third Quarter 2026 Financial Results
BRLIBio-Reference Laboratories2026-11-04 21:23 EST
OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results
REGNRegeneron Pharmaceuticals2026-10-30 10:30 EST
Regeneron Reports Third Quarter 2026 Financial and Operating Results
SABSSAB Biotherapeutics2026-10-29 12:30 EST
SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08:30 AM ET
BMYBMYBristol-Myers Squibb Company2026-10-29 10:59 EST
Bristol Myers Squibb Reports Third Quarter Financial Results for 2026
BRLIBio-Reference Laboratories2026-10-28 12:52 EST
OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026
OSUROraSure Technologies, Inc.2026-10-26 20:05 EST
OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th
Exagen
Autoimmune Diagnostics Exagen provides diagnostic testing for autoimmune and rheumatic diseases. Its tests are designed to help clinicians resolve diagnostically complex cases and support ongoing disease management. AVISE CTD AVISE CTD is the company's flagship testing service for lupus and other connective-tissue diseases. It combines...
Recent company news
XGNExagen2026-11-10 12:30 EST
Exagen Inc. Reports Third Quarter 2026 Financial Results
XGNExagen2026-10-29 13:00 EST
Exagen Inc. to Participate in Upcoming Investor Conferences
XGNExagen2026-10-27 13:00 EST
Exagen to Announce Third Quarter Financial Results on November 10, 2026
XGNExagen2026-08-04 12:00 EST
Exagen Inc. Reports Second Quarter 2026 Financial Results
XGNExagen2026-07-28 13:00 EST
Exagen Inc. to Participate in Upcoming Investor Conference
Stock data
- Close
- 3.80 USD
- Market cap
- 116.45M USD
- Exchange
- NASDAQ
- Sector
- MedTech
- Location
- United States
